$63.3 Thousand is the total value of Telemetry Investments, L.L.C.'s 146 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRput | $11,473 | -99.9% | 30,000 | 0.0% | 18.13% | +32.0% | |
| SPKB | SILVER SPIKE ACQUISITN CORP | $2,825 | -99.9% | 280,000 | 0.0% | 4.46% | +25.4% | |
| TRAJECTORY ALPHA ACQUISITION | $1,065 | -99.9% | 106,000 | 0.0% | 1.68% | +25.1% | ||
| SHUAA PARTNERS ACQUISTN CORPunit 02/24/2027 | $1,028 | -99.9% | 100,000 | 0.0% | 1.62% | +25.1% | ||
| HOME PLATE ACQUISITION CORP | $1,012 | -99.9% | 100,000 | 0.0% | 1.60% | +26.8% | ||
| BATTERY FUTURE ACQUISITION C | $917 | -99.9% | 89,256 | 0.0% | 1.45% | +25.7% | ||
| HEALTHCARE AI ACQUISITION CO | $859 | -99.9% | 83,900 | 0.0% | 1.36% | +25.1% | ||
| HEALTHWELL ACQUISITION CORP | $778 | -99.9% | 78,500 | 0.0% | 1.23% | +26.1% | ||
| SOUTHPORT ACQUISITION CORP | $713 | -99.9% | 70,000 | 0.0% | 1.13% | +25.5% | ||
| FZT | FAST ACQUISITION CORP IIcl a | $695 | -99.9% | 69,440 | 0.0% | 1.10% | +25.6% | |
| BIOPLUS ACQUISITION CORP | $685 | -99.9% | 66,607 | 0.0% | 1.08% | +26.5% | ||
| VALUENCE MERGER CORP Iunit 02/18/2027 | $677 | -99.9% | 65,000 | 0.0% | 1.07% | +26.2% | ||
| GRAF ACQUISITION CORP IV | $593 | -99.9% | 59,561 | 0.0% | 0.94% | +25.9% | ||
| INTELLIGENT MEDI ACQSITN CORunit 11/05/2026 | $418 | -99.9% | 40,796 | 0.0% | 0.66% | +25.7% | ||
| MSOS | ADVISORSHARES TRpure us cannabis | $350 | -99.9% | 50,000 | 0.0% | 0.55% | -3.2% | |
| POWERUP ACQUISITION CORPunit 02/18/2032 | $320 | -99.9% | 31,044 | 0.0% | 0.51% | +25.2% | ||
| CARTESIAN GROWTH CORP IIunit 07/12/2028 | $256 | -99.9% | 25,000 | 0.0% | 0.40% | +26.2% | ||
| FUTURE HEALTH ESG CORP | $148 | -99.9% | 14,632 | 0.0% | 0.23% | +25.1% | ||
| TCON | TRACON PHARMACEUTICALS INC | $145 | -99.9% | 97,000 | 0.0% | 0.23% | +10.1% | |
| ALLT | ALLOT LTD | $53 | -99.9% | 15,500 | 0.0% | 0.08% | +7.7% | |
| PEAR THERAPEUTICS INC*w exp 12/03/202 | $13 | -99.9% | 85,742 | 0.0% | 0.02% | +10.5% | ||
| ARTEMIS STRATEGIC INVT CORP*w exp 09/30/202 | $12 | -99.9% | 152,150 | 0.0% | 0.02% | +35.7% | ||
| BIOTW | BIOTECH ACQUISITION COMPANY*w exp 11/30/202 | $10 | -99.9% | 153,694 | 0.0% | 0.02% | +33.3% | |
| ALPINE ACQUISITION CORPORATI*w exp 05/01/202 | $10 | -99.9% | 100,000 | 0.0% | 0.02% | -27.3% | ||
| INKAW | KLUDEIN I ACQUISITION CORP*w exp 07/08/202 | $10 | -99.9% | 119,512 | 0.0% | 0.02% | -11.1% | |
| FUTURE HEALTH ESG CORP*w exp 99/99/999 | $10 | -100.0% | 149,885 | 0.0% | 0.02% | -74.6% | ||
| TBCPW | THUNDER BRIDGE CAP PRTNRS II*w exp 02/01/202 | $8 | -99.9% | 98,100 | 0.0% | 0.01% | 0.0% | |
| SLAMW | SLAM CORP*w exp 02/23/202 | $7 | -99.9% | 79,034 | 0.0% | 0.01% | +83.3% | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $7 | -99.3% | 122,810 | 0.0% | 0.01% | +1000.0% | |
| TERRAN ORBITAL CORPORATION*w exp 03/25/202 | $6 | -100.0% | 59,675 | 0.0% | 0.01% | -40.0% | ||
| PUCKW | GOAL ACQUISITIONS CORP*w exp 02/11/202 | $6 | -99.9% | 133,449 | 0.0% | 0.01% | +12.5% | |
| MERCURY ECOM ACQUISITION COR*w exp 07/27/202 | $6 | -99.9% | 115,900 | 0.0% | 0.01% | 0.0% | ||
| PHOENIX BIOTECH ACQUISITION*w exp 09/01/202 | $5 | -100.0% | 125,114 | 0.0% | 0.01% | -65.2% | ||
| RAMMW | ARIES I ACQUISITION CORP*w exp 03/18/202 | $5 | -99.9% | 87,753 | 0.0% | 0.01% | -33.3% | |
| CTAQW | CARNEY TECHNOLOGY ACQU CORP*w exp 11/30/202 | $5 | -99.5% | 80,521 | 0.0% | 0.01% | +700.0% | |
| WEJO GROUP LIMITED*w exp 11/18/202 | $5 | -100.0% | 120,856 | 0.0% | 0.01% | -52.9% | ||
| KINZW | KINS TECHNOLOGY GROUP INC*w exp 10/14/202 | $4 | -99.9% | 119,843 | 0.0% | 0.01% | +50.0% | |
| STONEBRIDGE ACQUISITION CORP*w exp 03/31/202 | $3 | -99.9% | 124,473 | 0.0% | 0.01% | -16.7% | ||
| SPRINGBIG HOLDINGS INC*w exp 06/14/202 | $3 | -100.0% | 153,101 | 0.0% | 0.01% | -66.7% | ||
| BATTERY FUTURE ACQUISITION C*w exp 99/99/999 | $3 | -99.9% | 44,628 | 0.0% | 0.01% | -16.7% | ||
| TIOAW | TIO TECH A*w exp 04/12/202 | $2 | -100.0% | 69,397 | 0.0% | 0.00% | -50.0% | |
| NOGIN INC*w exp 08/26/202 | $2 | -100.0% | 80,627 | 0.0% | 0.00% | -66.7% | ||
| SHAPEWAYS HOLDINGS INC*w exp 09/29/202 | $2 | -100.0% | 126,455 | 0.0% | 0.00% | -62.5% | ||
| RUBICON TECHNOLOGIES INC*w exp 04/01/202 | $2 | -100.0% | 38,112 | 0.0% | 0.00% | -50.0% | ||
| REVELATION BIOSCIENCES INC*w exp 01/10/202 | $2 | -100.0% | 143,115 | 0.0% | 0.00% | -62.5% | ||
| SPKBW | SILVER SPIKE ACQUISITN CORP*w exp 02/26/202 | $2 | -99.9% | 56,156 | 0.0% | 0.00% | 0.0% | |
| HEALTHCARE AI ACQUISITION CO*w exp 99/99/999 | $2 | -100.0% | 41,950 | 0.0% | 0.00% | -62.5% | ||
| TRAJECTORY ALPHA ACQUISITION*w exp 99/99/999 | $2 | -100.0% | 53,000 | 0.0% | 0.00% | -50.0% | ||
| HEALTHWELL ACQUISITION CORP*w exp 08/05/202 | $1 | -100.0% | 49,396 | 0.0% | 0.00% | -77.8% | ||
| NEWCOURT ACQUISITION CORP*w exp 01/22/202 | $1 | -100.0% | 129,000 | 0.0% | 0.00% | -83.3% | ||
| DP CAP ACQUISITION CORP I*w exp 11/08/202 | $1 | -100.0% | 132,180 | 0.0% | 0.00% | -92.3% | ||
| AGGRW | AGILE GROWTH CORP*w exp 03/09/202 | $1 | -100.0% | 51,759 | 0.0% | 0.00% | -33.3% | |
| SOUTHPORT ACQUISITION CORP*w exp 99/99/999 | $1 | -100.0% | 35,000 | 0.0% | 0.00% | -60.0% | ||
| BIOPLUS ACQUISITION CORP*w exp 12/02/202 | $0 | -100.0% | 33,303 | 0.0% | 0.00% | -100.0% | ||
| HOME PLATE ACQUISITION CORP*w exp 09/30/202 | $0 | -100.0% | 48,401 | 0.0% | 0.00% | -100.0% | ||
| THRIVE ACQUISITION CORPORATI*w exp 10/31/202 | $0 | -100.0% | 60,350 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.